These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 16413875)

  • 21. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
    Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J
    Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G-CSF treatment for STEMI: final 3-year follow-up of the randomised placebo-controlled STEM-AMI trial.
    Achilli F; Malafronte C; Maggiolini S; Lenatti L; Squadroni L; Gibelli G; Capogrossi MC; Dadone V; Gentile F; Bassetti B; Di Gennaro F; Camisasca P; Calchera I; Valagussa L; Colombo GI; Pompilio G;
    Heart; 2014 Apr; 100(7):574-81. PubMed ID: 24415665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.
    Zohlnhöfer D; Ott I; Mehilli J; Schömig K; Michalk F; Ibrahim T; Meisetschläger G; von Wedel J; Bollwein H; Seyfarth M; Dirschinger J; Schmitt C; Schwaiger M; Kastrati A; Schömig A;
    JAMA; 2006 Mar; 295(9):1003-10. PubMed ID: 16507801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.
    Assmus B; Leistner DM; Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Sedding D; Yu J; Corti R; Mathey DG; Barth C; Mayer-Wehrstein C; Burck I; Sueselbeck T; Dill T; Hamm CW; Tonn T; Dimmeler S; Zeiher AM;
    Eur Heart J; 2014 May; 35(19):1275-83. PubMed ID: 24569031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study.
    Beitnes JO; Hopp E; Lunde K; Solheim S; Arnesen H; Brinchmann JE; Forfang K; Aakhus S
    Heart; 2009 Dec; 95(24):1983-9. PubMed ID: 19833610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.
    Sürder D; Manka R; Lo Cicero V; Moccetti T; Rufibach K; Soncin S; Turchetto L; Radrizzani M; Astori G; Schwitter J; Erne P; Zuber M; Auf der Maur C; Jamshidi P; Gaemperli O; Windecker S; Moschovitis A; Wahl A; Bühler I; Wyss C; Kozerke S; Landmesser U; Lüscher TF; Corti R
    Circulation; 2013 May; 127(19):1968-79. PubMed ID: 23596006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty].
    Tomaszuk-Kazberuk A; Korecki J; Kochman W; Dobrzycki S; Musiał WJ
    Przegl Lek; 2002; 59(8):638-41. PubMed ID: 12638338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function.
    Leone AM; Rutella S; Bonanno G; Abbate A; Rebuzzi AG; Giovannini S; Lombardi M; Galiuto L; Liuzzo G; Andreotti F; Lanza GA; Contemi AM; Leone G; Crea F
    Eur Heart J; 2005 Jun; 26(12):1196-204. PubMed ID: 15734770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials.
    Zhang SN; Sun AJ; Ge JB; Yao K; Huang ZY; Wang KQ; Zou YZ
    Int J Cardiol; 2009 Aug; 136(2):178-85. PubMed ID: 18644638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction.
    Traverse JH; McKenna DH; Harvey K; Jorgenso BC; Olson RE; Bostrom N; Kadidlo D; Lesser JR; Jagadeesan V; Garberich R; Henry TD
    Am Heart J; 2010 Sep; 160(3):428-34. PubMed ID: 20826249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction.
    Nilsson L; Hallén J; Atar D; Jonasson L; Swahn E
    Heart; 2012 Jan; 98(1):31-6. PubMed ID: 21727201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocyte colony-stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single-blind, randomized, placebo-controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM-AMI) Trial.
    Achilli F; Malafronte C; Lenatti L; Gentile F; Dadone V; Gibelli G; Maggiolini S; Squadroni L; Di Leo C; Burba I; Pesce M; Mircoli L; Capogrossi MC; Di Lelio A; Camisasca P; Morabito A; Colombo G; Pompilio G;
    Eur J Heart Fail; 2010 Oct; 12(10):1111-21. PubMed ID: 20861135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of autologous bone marrow derived CD34+ stem cells on the left ventricular function following myocardial infarction].
    Balogh L; Czuriga I; Hunyadi J; Galuska L; Kristóf E; Edes I
    Orv Hetil; 2007 Feb; 148(6):243-9. PubMed ID: 17344174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.
    Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C
    Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial.
    Nicolau JC; Furtado RHM; Silva SA; Rochitte CE; Rassi A; Moraes JBMC; Quintella E; Costantini CR; Korman APM; Mattos MA; Castello HJ; Caixeta A; Dohmann HFR; de Carvalho ACC;
    Clin Cardiol; 2018 Mar; 41(3):392-399. PubMed ID: 29569254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI).
    Li ZQ; Zhang M; Jing YZ; Zhang WW; Liu Y; Cui LJ; Yuan L; Liu XZ; Yu X; Hu TS
    Int J Cardiol; 2007 Jan; 115(1):52-6. PubMed ID: 16822566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intracoronary transfer autologous bone marrow stem cells can improve cardiac function in patients with left ventricular dysfunction after myocardial infarction].
    Nie Y; Guo YH; Guo LJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 39(6):634-7. PubMed ID: 18087557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Successful therapy of patients in therapy-resistant cardiogenic shock with intracoronary, autologous bone marrow stem cell transplantation].
    Brehm M; Strauer BE
    Dtsch Med Wochenschr; 2007 Sep; 132(38):1944-8. PubMed ID: 17853349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial.
    Cerisano G; Buonamici P; Valenti R; Sciagrà R; Raspanti S; Santini A; Carrabba N; Dovellini EV; Romito R; Pupi A; Colonna P; Antoniucci D
    Eur Heart J; 2014 Jan; 35(3):184-91. PubMed ID: 24104875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.
    Eitel I; Wöhrle J; Suenkel H; Meissner J; Kerber S; Lauer B; Pauschinger M; Birkemeyer R; Axthelm C; Zimmermann R; Neuhaus P; Brosteanu O; de Waha S; Desch S; Gutberlet M; Schuler G; Thiele H
    J Am Coll Cardiol; 2013 Apr; 61(13):1447-54. PubMed ID: 23466078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.